Patents/Assignees

DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN

1 patent in portfolio

US12559770utility2026
MSBI Sequences as an Early Marker for the Future Development of Cancer and Diseases of the CNS and as a Target for the Treatment and Prevention of These Diseases
0 cites